| Literature DB >> 26067991 |
Shu-Xia Guo1,2, Yi-Zhong Yan3, La-Ti Mu4, Qiang Niu5, Jia He6, Jia-Ming Liu7, Shu-Gang Li8,9, Jing-Yu Zhang10, Heng Guo11, Dong-Sheng Rui12.
Abstract
OBJECTIVE: We aimed to investigate whether free fatty acid (FFA) levels in hypertensive patients result from increased blood pressure or the accompanying condition of insulin resistance (IR). Furthermore, we aimed to study the role of IR in the onset and development of hypertension and then provide a basis for the prevention and treatment of hypertension and metabolic syndrome (MS). DESIGN AND METHODS: The study included 68 essential hypertensive patients without IR, 87 normotensive subjects with IR, 82 essential hypertensive patients with IR and 74 normotensive subjects without IR. Analysis of covariance was used to compare FFA concentrations among the four groups to determine the association between FFA concentrations and hypertension and IR.Entities:
Keywords: FFA; IR; Uyghur; hypertension
Mesh:
Substances:
Year: 2015 PMID: 26067991 PMCID: PMC4483717 DOI: 10.3390/ijerph120606582
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Balancing tests for SBP, DBP and HOMA-IR among the four groups.
| Index | With IR ( | With Hypertension ( | With Hypertension and IR ( | Normal ( |
|
|---|---|---|---|---|---|
| SBP | - | 145.35 ± 13.24 | 146.90 ± 18.21 | - | 0.813 |
| 111.06 ± 10.24 | - | - | 114.26 ± 9.82 | 0.069 | |
| DBP | - | 92.37 ± 11.12 | 94.78 ± 12.51 | - | 0.996 |
| 71.15 ± 8.87 | - | - | 72.91 ± 7.42 | 0.223 | |
| HOMA-IR | - | 0.68 ± 0.28 | - | 0.69 ± 0.34 | 0.935 |
| 4.02 ± 2.36 | - | 4.22 ± 2.34 | - | 0.786 |
Notes: IR = insulin resistance, SBP = Systolic blood pressure, DBP = Diastolic blood pressure, HOMA-IR = homeostatic model assessment of insulin resistance.
Index comparisons among the four groups.
| Index | With IR | With Hypertension | With Hypertension and IR | Normal |
| |
|---|---|---|---|---|---|---|
| ( | ( | ( | ( | |||
| Gender (male/female) | 46/41 | 38/30 | 48/34 | 36/38 | 1.651 | 0.648 |
| Age (year) | 39.30 ± 11.67 | 44.05 ± 10.91 | 45.43 ± 11.53 | 40.13 ± 11.67 | 4.883 | 0.003 |
| BMI (kg/m2) | 22.93 ± 3.50 | 24.58 ± 3.84 | 25.83 ± 3.79 | 22.06 ± 2.63 | 16.070 | <0.001 |
| TG (mmol/L) | 1.41 ± 0.98 | 1.35 ± 0.86 | 1.70 ± 0.97 | 1.02 ± 0.57 | 6.402 | <0.001 |
| TC (mmol/L) | 4.54 ± 1.04 | 4.75 ± 1.33 | 4.74 ± 0.96 | 4.22 ± 1.09 | 2.994 | 0.031 |
| HDL-C (mmol/L) | 1.19 ± 0.29 | 1.16 ± 0.30 | 1.08 ± 0.29 | 1.29 ± 0.26 | 5.796 | 0.001 |
| LDL-C (mmol/L) | 2.48 ± 0.84 | 2.67 ± 0.67 | 2.70 ± 0.62 | 2.32 ± 0.54 | 3.922 | 0.009 |
| FFA (mg/L) | 0.52 ± 0.15 | 0.58 ± 0.25 | 0.73 ± 0.22 | 0.39 ± 0.11 | 23.614 | <0.001 |
Notes: IR = insulin resistance, BMI = body mass index, TG = triglyceride, TC = total cholesterol, HDL-C = high-density lipoprotein cholesterol, LDL-C =low-density lipoprotein cholesterol, FFA = free fatty acid.
Figure 1Comparisons of adjusted means among the four groups.
Multiple comparisons of adjusted mean FFA levels.
| Groups |
| 95% CI |
|---|---|---|
| With hypertension and IR/with IR | <0.001 | (0.114, 0.243) |
| With hypertension and IR/with hypertension | 0.002 | (0.048, 0.201) |
| With hypertension and IR/normal | <0.001 | (0.013, 0.162) |
| With IR/normal | 0.007 | (0.039, 0.277) |
| With hypertension/normal | <0.001 | (0.102, 0.247) |
| With IR/with hypertension | 0.170 | (−0.131, 0.023) |
Interaction analysis by analysis of covariance.
| Source | Type β Sum of Squares | df | Mean Square |
| Sig. |
|---|---|---|---|---|---|
| Corrected Model | 1.074 a | 5 | 0.215 | 3.348 | 0.006 |
| Intercept | 0.736 | 1 | 0.736 | 11.462 | 0.001 |
| SBP | 0.022 | 1 | 0.022 | 3.745 | 0.048 |
| DBP | 0.377 | 1 | 0.377 | 5.876 | 0.016 |
| IR | 0.256 | 1 | 0.256 | 3.986 | 0.046 |
| IR
| 0.012 | 1 | 0.012 | 1.220 | 0.270 |
| IR
| 0.143 | 1 | 0.143 | 1.189 | 0.277 |
| Error | 28.751 | 448 | 0.064 | ||
| Total | 168.672 | 454 | |||
| Corrected Total | 29.826 | 453 |
Note: a R squared = 0.036 (Adjusted R squared = 0.025).
Multivariate logistic regression analysis of FFA levels with hypertension and IR.
| Variable | Index | β | SE | Waldχ2 |
| OR | 95%CI for OR | |
|---|---|---|---|---|---|---|---|---|
| Hypertension | FFA (mmol/L) | <0.40 | - | - | - | - | - | - |
| 0.40~ | -0.41 | 0.61 | 0.446 | 0.504 | 0.66 | (0.20, 2.21) | ||
| 0.62~ | 0.96 | 0.59 | 2.599 | 0.107 | 2.60 | (0.81, 8.30) | ||
| 0.79~ | 1.878 | 0.65 | 8.273 | 0.004 | 6.54 | (1.82, 23.52) | ||
| HOMA-IR | FFA (mmol/L) | <0.40 | - | - | - | - | - | - |
| 0.40~ | 1.54 | 0.62 | 6.111 | 0.013 | 4.67 | (1.38, 15.84) | ||
| 0.62~ | 1.55 | 0.59 | 6.801 | 0009 | 4.72 | (1.47, 15.16) | ||
| 0.79~ | 1.69 | 0.58 | 8.250 | 0.004 | 5.40 | (1.71, 17.06) |